TY  - GEN
AU  - Taburet,Anne-Marie
AU  - Raguin,Gilles
AU  - Le Tiec,Clotilde
AU  - Droz,Cécile
AU  - Barrail,Aurélie
AU  - Vincent,Isabelle
AU  - Morand-Joubert,Laurence
AU  - Chêne,Geneviève
AU  - Clavel,François
AU  - Girard,Pierre-Marie
TI  - Interactions between amprenavir and the lopinavir-ritonavir combination in heavily pretreated patients infected with human immunodeficiency virus
SN  - 0009-9236
PY  - 2004///0511
KW  - Administration, Oral
KW  - Adult
KW  - Antiretroviral Therapy, Highly Active
KW  - Biological Availability
KW  - Carbamates
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Drug Interactions
KW  - Drug Therapy, Combination
KW  - Female
KW  - Follow-Up Studies
KW  - Furans
KW  - HIV Infections
KW  - diagnosis
KW  - Humans
KW  - Lopinavir
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Probability
KW  - Pyrimidinones
KW  - administration & dosage
KW  - Risk Assessment
KW  - Ritonavir
KW  - Salvage Therapy
KW  - Severity of Illness Index
KW  - Single-Blind Method
KW  - Statistics, Nonparametric
KW  - Sulfonamides
KW  - Survival Rate
KW  - Treatment Outcome
KW  - Viral Load
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.clpt.2003.12.013
ER  -